Pharmacovigilance and Drug Safety Software Market 2018-2024 - Analysis Report By Functionality, Delivery Mode, End Users - ResearchAndMarkets.com

September 6, 2018

DUBLIN--(BUSINESS WIRE)--Sep 6, 2018--The “Pharmacovigilance and Drug Safety Software Market Size, Share & Trends Analysis Report By Functionality, By Delivery Mode, By End Use (Pharmaceutical & Biotech Companies, CROs, BPOs), And Segment Forecasts, 2018 - 2024” report has been added to ResearchAndMarkets.com’s offering.

The global pharmacovigilance and drug safety software market size is expected to reach USD 207.7 million by 2024, presenting a CAGR of 6.5% during the forecast period. Increasing number of adverse drug reactions (ADR) is a key factor for market growth. ADR imposes a significant burden on research organizations and companies. To curb this problem, pharmaceutical companies are opting for contract outsourcing of these services.

Manufacturers are now striving to identify various ways of cost reduction and minimizing operational expenses by gradually shifting from being fully integrated pharmaceutical companies to sharing costs by collaborating with service providers. Outsourcing helps increase internal resource flexibility, improves timelines, and results in better outcomes in short as well as long terms. Outsourcing also helps achieve better pharmacovigilance (PV) through regulatory compliance, higher quality, better productivity, and improved strategic outcomes.

PV service providers, in an attempt to ensure sustainability, are providing customized and end-to-end solutions to meet consumer needs. These firms are also incorporating integrated technologies such as electronic data capture and hosting of PV warehousing for aggregating cross industry data for benefit risk evaluation. Furthermore, the fact that service providers are now operating via a flexible and variable pricing structure and achieving operational excellence through constant product updates is expected to boost usage rates over the forecast period.

Key Topics Covered:

Chapter 1 Research Methodology & Scope

Chapter 2 Executive Summary

Chapter 3 Market Snapshot

Chapter 4 Market Variables, Trends& Scope

Chapter 5 Functionality Estimates & Trend Analysis

Chapter 6 Delivery Mode Estimates & Trend Analysis

Chapter 7 End-use Estimates & Trend Analysis

Chapter 8 Regional Estimates & Trend Analysis, by Functionality, Delivery Mode, and End-use

Chapter 9 Competitive Landscape

AB cubeMax ApplicationEnnov Solutions, Inc.ArisGlobalEXTEDO GmbHOnline Business Applications, Inc.Oracle CorporationSparta Systems, Inc.United BioSource CorporationRelsysFor more information about this report visit https://www.researchandmarkets.com/research/4bhjk6/pharmacovigilance?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180906005334/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Software,Drug Discovery



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/06/2018 04:22 AM/DISC: 09/06/2018 04:22 AM


Update hourly